Daily Current Affairs : 9-August-2023
In recent news, the Ministry of Health and Family Welfare has drawn attention to the increasing prevalence of genetic conditions, particularly Sickle Cell Disease and Glucose-6-Phosphate Dehydrogenase deficiency (G6PD), in tribal areas. These health concerns shed light on the challenges faced by vulnerable populations and emphasize the need for awareness, prevention, and medical support.
Understanding Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD)
An Intricate Genetic Disorder
G6PD deficiency is a genetic disorder that exerts its effects on red blood cells. These cells play a vital role in carrying oxygen from the lungs to various tissues in the body. Individuals with G6PD deficiency experience a malfunction in an enzyme called glucose-6-phosphate dehydrogenase, leading to the premature breakdown of red blood cells. This phenomenon is known as hemolysis, which contributes to a range of health challenges.
Origins and Prevalence
The initial classification of G6PD-deficient variants took place in 1966, followed by an updated categorization by the World Health Organization’s (WHO) Working Group in 1985. The condition predominantly affects populations in specific regions, including parts of Africa, Asia, the Mediterranean, and the Middle East.
Impacts of Glucose-6-Phosphate Dehydrogenase Deficiency
Hemolytic Anemia: A Prominent Consequence
The most prevalent medical issue linked to glucose-6-phosphate dehydrogenase deficiency is hemolytic anemia. This condition arises when the destruction of red blood cells surpasses the body’s ability to replenish them. As a result, individuals experience a range of symptoms such as paleness, jaundice (yellowing of the skin and eyes), dark urine, fatigue, shortness of breath, and an accelerated heart rate.
Neonatal Jaundice
G6PD deficiency also significantly contributes to neonatal jaundice, a condition characterized by the yellowing of an infant’s skin and eyes shortly after birth. The impairment in red blood cells’ stability amplifies the risk of jaundice in newborns, necessitating medical attention and interventions.
Addressing the Challenge: Education and Medical Support
Raising Awareness
To effectively tackle the rising prevalence of G6PD deficiency and other genetic conditions, it is imperative to enhance public awareness. Education campaigns targeted at tribal communities can aid in early detection, management, and prevention of these conditions.
Medical Interventions
Medical professionals play a crucial role in managing G6PD deficiency. Timely diagnosis and appropriate treatment can alleviate symptoms, enhance quality of life, and mitigate potential complications. Newborn screening programs should be expanded to identify infants at risk of developing jaundice due to G6PD deficiency, enabling prompt medical interventions.
Important Points:
Understanding Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD)
- Genetic disorder affecting red blood cells’ oxygen-carrying function.
- Enzyme glucose-6-phosphate dehydrogenase malfunction leads to premature red blood cell breakdown (hemolysis).
- G6PD variants classified in 1966 and updated by WHO in 1985.
- Prevalent in Africa, Asia, Mediterranean, and Middle East.
Impacts of Glucose-6-Phosphate Dehydrogenase Deficiency
- Hemolytic anemia: Red blood cells destruction surpasses replenishment, causing symptoms like paleness, jaundice, dark urine, fatigue, and rapid heart rate.
- Neonatal jaundice: Newborns with G6PD deficiency at risk of yellowing skin and eyes after birth.
Addressing the Challenge: Education and Medical Support
- Importance of raising public awareness in tribal communities.
- Education campaigns aid in early detection, management, and prevention.
- Medical professionals’ role crucial in timely diagnosis and treatment.
- Newborn screening programs needed to identify jaundice risk in G6PD-deficient infants.
Why In News
The Ministry of Health and Family Welfare emphasized a concerning trend as genetic conditions like Sickle Cell Disease and G-6 PD deficiency continue to surge within tribal communities. This underscores the urgent need for targeted interventions and comprehensive healthcare initiatives to address these escalating challenges at their root.
MCQs about G6PD Deficiency in Tribal Regions
-
What are the regions most affected by Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency?
A. North America and Europe.
B. South America and Australia.
C. Africa, Asia, Mediterranean, and the Middle East.
D. Arctic and Antarctic regions.
-
What are the symptoms associated with hemolytic anemia caused by G6PD deficiency?
A. Increased blood clotting and hypertension.
B. Muscle weakness and joint pain.
C. Paleness, jaundice, dark urine, fatigue, and rapid heart rate.
D. Elevated body temperature and skin rashes.
-
How can the impact of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency be mitigated in newborns?
A. Increased caffeine intake.
B. Timely diagnosis and treatment through newborn screening programs.
C. High-intensity exercise regimen.
D. Consumption of iron-rich foods.
Boost up your confidence by appearing our Weekly Current Affairs Multiple Choice Questions
